National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival

被引:49
|
作者
Guttmann, David M. [1 ]
Kobie, Julie [2 ]
Grover, Surbhi [1 ]
Lin, Alexander [1 ]
Lukens, John N. [1 ]
Mitra, Nandita [2 ]
Rhodes, Karin V. [3 ,4 ,5 ]
Feng, Weiwei [2 ]
Swisher-McClure, Samuel [1 ]
机构
[1] Hosp Univ Penn, Dept Radiat Oncol, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Hofstra Northwell Med Sch, Dept Emergency Med, Hempstead, NY USA
[4] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[5] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2018年 / 40卷 / 06期
关键词
disparities; head and neck cancer; head and neck neoplasms; package time; radiotherapy; surgery; POSTOPERATIVE RADIATION-THERAPY; SQUAMOUS-CELL CARCINOMA; RANDOMIZED-TRIAL; UNITED-STATES; CARE; RADIOTHERAPY; DIAGNOSIS; SURGERY; ACCESS; RISK;
D O I
10.1002/hed.25091
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundThe purpose of this study was to determine national disparities in head and neck cancer treatment package time (the time interval from surgery through the completion of radiation) and the associated impact on survival. MethodsWe conducted an observational cohort study using the National Cancer Database of 15234 patients with resected head and neck cancer who underwent adjuvant radiotherapy from 2004-2012. Predictors of prolonged package time were identified by multivariable linear regression. Survival outcomes were assessed using a multivariable Cox model. ResultsMean package time was 100 days (SD 23). Package time was 7.52 days (95% confidence interval [CI] 6.23-8.81; P<.001) longer with Medicaid versus commercial insurance. Low income and African American race also predicted for longer package times. All-cause mortality increased an average of 4% with each 1 week increase in treatment package time (hazard ratio [HR] 1.04; 95% CI 1.03-1.05; P<.001). ConclusionSignificant national socioeconomic disparities exist in treatment package time. Treatment delays in this setting may contribute to worse survival outcomes.
引用
收藏
页码:1147 / 1155
页数:9
相关论文
共 50 条
  • [41] L-Glutamine and Survival of Patients with Locally Advanced Head and Neck Cancer Receiving Chemoradiotherapy
    Tsujimoto, Takae
    Wasa, Masafumi
    Inohara, Hidenori
    Ito, Toshinori
    NUTRIENTS, 2023, 15 (19)
  • [42] Chemotherapy in the treatment of locally advanced head and neck cancer
    Forastiere, Arlene A.
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (08) : 701 - 707
  • [43] Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: A report of randomized trial
    Huilgol, Nagraj G.
    Gupta, Sapna
    Sridhar, C. R.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (04) : 492 - 496
  • [44] Oral hygiene and the overall survival of head and neck cancer patients
    Chang, Chan-Chi
    Lee, Wei-Ting
    Hsiao, Jenn-Ren
    Ou, Chun-Yen
    Huang, Cheng-Chih
    Tsai, Sen-Tien
    Chen, Ken-Chung
    Huang, Jehn-Shyun
    Wong, Tung-Yiu
    Lai, Yu-Hsuan
    Wu, Yuan-Hua
    Hsueh, Wei-Ting
    Wu, Shang-Yin
    Yen, Chia-Jul
    Chang, Jong-Yang
    Lin, Chen-Lin
    Weng, Ya-Ling
    Yang, Han-Chien
    Chen, Yu-Shan
    Chang, Jeffrey S.
    CANCER MEDICINE, 2019, 8 (04): : 1854 - 1864
  • [45] Adaptive radiotherapy in locally advanced head and neck cancer: The importance of reduced margins
    Enocson, Hedda
    Haraldsson, Andre
    Engstrom, Per
    Ceberg, Sofie
    Gebre-Medhin, Maria
    Adrian, Gabriel
    Rosenschold, Per Munck af
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2025, 33
  • [46] The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy
    Polesel, Jerry
    Furlan, Carlo
    Birri, Silvia
    Giacomarra, Vittorio
    Vaccher, Emanuela
    Grando, Giuseppe
    Gobitti, Carlo
    Navarria, Federico
    Schioppa, Ornella
    Minatel, Emilio
    Bidoli, Ettore
    Barzan, Luigi
    Franchin, Giovanni
    ORAL ONCOLOGY, 2017, 67 : 175 - 182
  • [47] Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer
    McMillan, Matthew T.
    Ojerholm, Eric
    Verma, Vivek
    Higgins, Kristin A.
    Singhal, Sunil
    Predina, Jarrod D.
    Berman, Abigail T.
    Grover, Surbhi
    Robinson, Cliff G.
    Simone, Charles B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (05): : 1142 - 1152
  • [48] Cetuximab in the management of locoregionally advanced head and neck cancer: Expanding the treatment options?
    Bourhis, Jean
    Lefebvre, Jean-Louis
    Vermorken, Jan B.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (11) : 1979 - 1989
  • [49] Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis
    Stokes, William A.
    Amini, Arya
    Jones, Bernard L.
    McDermott, Jessica D.
    Raben, David
    Ghosh, Debashis
    Goddard, Julie A.
    Bowles, Daniel W.
    Karam, Sana D.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (06): : 1113 - 1121
  • [50] Impact of Comorbidity on Initial Treatment and Overall Survival in Elderly Head and Neck Cancer Patients
    Chokshi, Saurin
    Ghobadi, Armin
    Athar, Mohammed
    Shah, Sachin
    Dowell, Jonathan
    ANTICANCER RESEARCH, 2014, 34 (10) : 5543 - 5546